Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Eases Up On Adverse Event Reporting During COVID-19

Mar 20 2020

• By Sarah Karlin-Smith

Binoculars hang on a wooden fence background

Additional Topics

United States Safety Coronavirus COVID-19 Post Market Regulation & Studies FDA Guidance Documents Drug Safety BioPharmaceutical

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window